These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 22427614

  • 1. Efficacy of posaconazole in a murine model of disseminated infection caused by Apophysomyces variabilis.
    Salas V, Pastor FJ, Calvo E, Sutton DA, Chander J, Mayayo E, Alvarez E, Guarro J.
    J Antimicrob Chemother; 2012 Jul; 67(7):1712-5. PubMed ID: 22427614
    [Abstract] [Full Text] [Related]

  • 2. Experimental murine model of disseminated infection by Saksenaea vasiformis: successful treatment with posaconazole.
    Salas V, Pastor FJ, Calvo E, Sutton D, García-Hermoso D, Mayayo E, Dromer F, Fothergill A, Alvarez E, Guarro J.
    Med Mycol; 2012 Oct; 50(7):710-5. PubMed ID: 22458251
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole.
    Salas V, Pastor FJ, Calvo E, Alvarez E, Sutton DA, Mayayo E, Fothergill AW, Rinaldi MG, Guarro J.
    Antimicrob Agents Chemother; 2012 May; 56(5):2246-50. PubMed ID: 22290952
    [Abstract] [Full Text] [Related]

  • 4. Posaconazole efficacy in a murine disseminated infection caused by Paecilomyces lilacinus.
    Rodríguez MM, Pastor FJ, Serena C, Guarro J.
    J Antimicrob Chemother; 2009 Feb; 63(2):361-4. PubMed ID: 19054804
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fungal necrotizing fasciitis, an emerging infectious disease caused by Apophysomyces (Mucorales).
    Chander J, Stchigel AM, Alastruey-Izquierdo A, Jayant M, Bala K, Rani H, Handa U, Punia RS, Dalal U, Attri AK, Monzon A, Cano-Lira JF, Guarro J.
    Rev Iberoam Micol; 2015 Feb; 32(2):93-8. PubMed ID: 25576377
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT, Muzny CA, Swiatlo E, Legendre DP.
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Apophysomyces variabilis as an emerging pathogen in Mainland China.
    Li XY, Wang SJ, Huang GM, Zheng DY, Al-Odaini N, Pan KS, Zheng YQ, Cao CW.
    Mycoses; 2023 Sep; 66(9):795-800. PubMed ID: 37226871
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.
    Luo G, Gebremariam T, Lee H, French SW, Wiederhold NP, Patterson TF, Filler SG, Ibrahim AS.
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3340-7. PubMed ID: 23650163
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Therapeutic efficacy of posaconazole in a murine model of disseminated trichosporonosis.
    Treviño-Rangel Rde J, López LJ, Palma-Nicolás JP, Hernández-Bello R, González JG, González GM.
    J Antimicrob Chemother; 2014 Apr; 69(4):1075-8. PubMed ID: 24252752
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.